Technological advances in disease surveillance and monitoring, coupled with innovative public-private partnerships, are opening new avenues for infectious disease control and prevention. Integrated approaches to understanding disease emergence factors spanning human, domestic animal, and wildlife populations are gaining support and creating alignment among diverse institutions and stakeholders. These stakeholders include the food industry, the wildlife conservation community, government agencies responsible for human and animal health, and other organizations, ranging from the high tech industry to pharmaceutical companies.